Charité Disc Criticism

Charles Rosen of the University of California-Irvine Spine Center has expressed concern and asked that the FDA withdraw the discs from the market. He discussed his concerns in an article on TheStreet.com in May of 2005. Rosen questioned how Charité was approved due to its weak results and frequent life-threatening revision surgeries. Rosen has spoken publicly about the discouraging of scientific debate on Charité at the annual meeting of the North American Spine Society.